Miami Project to Cure Paralysis: This trial is an FDA-approved Phase I clinical trial designed to test the safety of autologous human Schwann cells in participants with chronic spinal cord injury receiving rehabilitation.A total of 10 participants will be enrolled in…
Month: February 2015
Miami Project Schwann Trial for Chronic SCI Begins Enrollment for 10 people
This new trial will be primarily focused on safety, but in addition it will involve a preliminary evaluation of the efficacy of combining Schwann cells with exercise and rehabilitation. They only have FDA approval to transplant a maximum of 10 people…
Review of preclinical studies and evaluation of clinical trials from Phase I to II
Investigational drugs for the treatment of spinal cord injury. Efforts in basic research have clarified mechanisms involved in spinal cord injury (SCI), and resulted in positive findings using experimental treatments including cell transplantation and drug administration preclinically. Based on accumulated…